Jennifer Zachary

Insider Reports History

Location
Rahway, NJ
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Jennifer Zachary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Zachary:

Company Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. EVP, General Counsel Common Stock 68,916 $8,211,453 $119.15 09 Feb 2026 Direct
REGENXBIO Inc. Director Common Stock 22,064 $175,850 $7.97 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39,815 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24,454 31 May 2024 Direct
Merck & Co., Inc. EVP, General Counsel Restricted Stock Unit 8,854 29 Apr 2025 Direct
Merck & Co., Inc. EVP, General Counsel Stock Option (Right to Buy) 0 09 Feb 2026 Direct

Insider Reports Filed by Jennifer Zachary

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRK Merck & Co., Inc. 09 Feb 2026 9 $0 4 EVP, General Counsel 09 Feb 2026, 16:01
MRK Merck & Co., Inc. 26 Jan 2026 1 +$1,244,014 4 EVP, General Counsel 28 Jan 2026, 16:19
RGNX REGENXBIO Inc. 30 May 2025 2 $0 4 Director 03 Jun 2025, 16:33
MRK Merck & Co., Inc. 29 Apr 2025 2 $0 4 EVP, General Counsel 01 May 2025, 18:03
MRK Merck & Co., Inc. 27 Jan 2025 1 +$2,489,929 4 EVP, General Counsel 29 Jan 2025, 18:29
RGNX REGENXBIO Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:43
MRK Merck & Co., Inc. 30 Apr 2024 1 $0 4 EVP, General Counsel 02 May 2024, 16:19
MRK Merck & Co., Inc. 02 Feb 2024 3 -$4,593,558 4 EVP, General Counsel 02 Feb 2024, 16:05
MRK Merck & Co., Inc. 22 Jan 2024 1 +$2,782,480 4 EVP, General Counsel 24 Jan 2024, 16:11
RGNX REGENXBIO Inc. 02 Jun 2023 2 $0 4 Director 06 Jun 2023, 17:11
MRK Merck & Co., Inc. 04 May 2023 1 -$2,250,834 4 EVP, General Counsel 05 May 2023, 17:13
MRK Merck & Co., Inc. 02 May 2023 1 $0 4 EVP, General Counsel 04 May 2023, 17:34
MRK Merck & Co., Inc. 03 Feb 2023 3 -$3,555,329 4 EVP, General Counsel 06 Feb 2023, 15:21
MRK Merck & Co., Inc. 23 Jan 2023 1 +$1,717,534 4 EVP, General Counsel 25 Jan 2023, 16:03
MRK Merck & Co., Inc. 28 Oct 2022 8 -$16,422,893 4 EVP, General Counsel 01 Nov 2022, 16:28
RGNX REGENXBIO Inc. 03 Jun 2022 2 $0 4 Director 07 Jun 2022, 16:26
RGNX REGENXBIO Inc. 03 Jun 2022 0 $0 3 Director 07 Jun 2022, 16:24
MRK Merck & Co., Inc. 03 May 2022 1 $0 4 EVP, General Counsel 05 May 2022, 17:17
MRK Merck & Co., Inc. 24 Feb 2022 1 +$1,354,054 4 EVP, General Counsel 28 Feb 2022, 15:35